Consolidated Statements of Changes in Stockholders’ Equity - USD ($) $ in Thousands	Total	Common Stock	Treasury Stock	Additional Paid-In Capital	Accumulated Deficit	Accumulated Other Comprehensive Loss
Beginning balance (in shares) at Dec. 31, 2019		39,251,000
Beginning balance (in shares) at Dec. 31, 2019			0
Beginning balance at Dec. 31, 2019	$ 114,601	$ 393	$ 0	$ 251,641	$ (136,473)	$ (960)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss) income	(13,473)				(13,473)
Other comprehensive (loss) income	(1,088)					(1,088)
Stock option exercises and employee stock plan purchases (in shares)		73,000
Stock option exercises and employee stock plan purchases	760	$ 1		759
Vesting of restricted stock awards (in shares)		847,000
Vesting of restricted stock awards	0	$ 8		(8)
Shares withheld to cover taxes (in shares)		(141,000)
Shares withheld to cover taxes	(2,129)	$ (2)		(2,127)
Issuance of common stock, net (in shares)		26,845,000
Issuance of common stock, net	394,334	$ 269		394,065
Fair value of replacement stock options related to precombination services	7,125			7,125
Stock-based compensation	14,075			14,075
Ending balance (in shares) at Dec. 31, 2020		66,875,000
Ending balance (in shares) at Dec. 31, 2020			0
Ending balance at Dec. 31, 2020	514,205	$ 669	$ 0	665,530	(149,946)	(2,048)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss) income	(71,279)				(71,279)
Other comprehensive (loss) income	1,563					1,563
Stock option exercises and employee stock plan purchases (in shares)		360,000
Stock option exercises and employee stock plan purchases	6,062	$ 3		6,059
Vesting of restricted stock awards (in shares)		611,000
Vesting of restricted stock awards	0	$ 6		(6)
Shares withheld to cover taxes (in shares)		(107,000)
Shares withheld to cover taxes	(2,046)	$ (1)		(2,045)
Stock-based compensation	$ 15,934			15,934
Ending balance (in shares) at Dec. 31, 2021		67,739,000
Ending balance (in shares) at Dec. 31, 2021	0		0
Ending balance at Dec. 31, 2021	$ 464,439	$ 677	$ 0	685,472	(221,225)	(485)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss) income	28,067				28,067
Other comprehensive (loss) income	(774)					(774)
Stock option exercises and employee stock plan purchases (in shares)		411,000
Stock option exercises and employee stock plan purchases	8,912	$ 4		8,908
Vesting of restricted stock awards (in shares)		845,000
Vesting of restricted stock awards	0	$ 9		(9)
Shares withheld to cover taxes (in shares)		(144,000)
Shares withheld to cover taxes	(7,759)	$ (1)		(7,758)
Repurchase of common stock (in shares)			1,339,000
Repurchase of common stock	(75,000)		$ (75,000)
Stock-based compensation	$ 29,262			29,262
Ending balance (in shares) at Dec. 31, 2022		68,851,000
Ending balance (in shares) at Dec. 31, 2022	1,339,000		1,339,000
Ending balance at Dec. 31, 2022	$ 447,147	$ 689	$ (75,000)	$ 715,875	$ (193,158)	$ (1,259)